Home » Topics » Conferences

Conferences
RSS

Potent antiretroviral activity shown for abacavir + protease inhibitor in HIV-positive patients

Feb. 3, 1998

Glutamate antagonists: a new frontier in stroke research

Feb. 2, 1998

Antithrombotic agents in stroke indications

Feb. 2, 1998

HMR's new ketolides extensively discussed at conference this week

Jan. 23, 1998

Abbott presents in vitro and in vivo efficacy data on tricyclic ketolides

Jan. 23, 1998

New class of macrolides developed at Abbott

Jan. 23, 1998

Desmycosin derivatives a focus of research at Pliva

Jan. 23, 1998

Streptogramins in the treatment of drug-resistant infections

Jan. 22, 1998

Innovative Therapies for Rheumatoid Arthritis

Jan. 22, 1998

Antischistosomal agent derived from myrrh tested in humans

Jan. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...